30-day FRN

Federal Register / Vol. 82, No. 191 / Wednesday, October 4, 2017 / Notices
Contact Person: Shang-Yi Anne Tsai,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4228, MSC 9550, Bethesda,
MD 20892, 301–827–5842, shangyi.tsai@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: September 28, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.

Dated: September 28, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2017–21264 Filed 10–3–17; 8:45 am]

Submission for OMB Review; 30-Day
Comment Request, The National
Institute of Mental Health Data Archive
(NDA), National Institute of Mental
Health

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting

sradovich on DSK3GMQ082PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of Microbiology, Infectious
Diseases and AIDS Initial Review Group
Microbiology and Infectious Diseases
Research Committee.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Microbiology and Infectious Diseases
Research Committee.
Date: October 30–31, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Frank S. De Silva, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room #3E72A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9834,
Bethesda, MD 20892934, (240) 669–5023,
fdesilva@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)

VerDate Sep<11>2014

20:18 Oct 03, 2017

Jkt 244001

National Institutes of Health

National Institutes of Health.
Notice.

AGENCY:

National Institutes of Health

ACTION:

National Institute on Drug Abuse;
Notice of Closed Meeting

SUMMARY:

[FR Doc. 2017–21265 Filed 10–3–17; 8:45 am]
BILLING CODE 4140–01–P

46253

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the Board of
Scientific Counselors, NIDA.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Drug Abuse,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDA.
Date: November 7, 2017.
Closed: 8:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: Intramural Research Program,
National Institute on Drug Abuse, NIH, Johns
Hopkins Bayview Campus, Baltimore, MD
21223.
Contact Person: Joshua Kysiak, Program
Specialist, Biomedical Research Center,
Intramural Research Program, National
Institute on Drug Abuse, NIH, DHHS, 251
Bayview Boulevard, Baltimore, MD 21224,
443–740–2465, kysiakjo@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: September 28, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–21266 Filed 10–3–17; 8:45 am]
BILLING CODE 4140–01–P

PO 00000

Frm 00043

Fmt 4703

Sfmt 4703

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below. This proposed
information collection was previously
published in the Federal Register on
July 11, 2017, and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Melba Rojas,
NIMH Project Clearance Liaison,
Science Policy and Evaluation Branch,
Office of Science Policy, Planning and
Communications, NIMH, Neuroscience
Center, 6001 Executive Boulevard, MSC
9667, Bethesda, Maryland 20892, call
301–443–4335, or email your request,
including your mailing address, to
nimhprapubliccomments@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
ADDRESSES:

The
National Institute of Mental Health
(NIMH), National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it

SUPPLEMENTARY INFORMATION:

E:\FR\FM\04OCN1.SGM

04OCN1

46254

Federal Register / Vol. 82, No. 191 / Wednesday, October 4, 2017 / Notices

displays a currently valid OMB control
number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: The National
Institute of Mental Health Data Archive
(NDA), REVISION, OMB Control
Number 0925–0667, National Institute
of Mental Health (NIMH), National
Institutes of Health (NIH).
Need and Use of Information
Collection: This REVISION request
seeks approval of updates to the
previously approved National Database
for Autism Research Data Access
Request and Data Use Certification, to
include additional terms/options for
data submission and access to meet the

needs of the expanding resource, and to
change the repository name to the NIMH
Data Archive (NDA). The NDA, formerly
known as the National Database for
Autism Research (NDAR), is an
infrastructure that allows for the
submission and storage of human
subjects data from researchers
conducting studies related to many
scientific domains, regardless of the
source of funding. The NIH and NIMH
developed this resource to allow for the
public collection of information from:
(1) Individuals who seek permission to
access data from the NDA for the
purpose of scientific investigation,
scholarship or teaching, or other forms
of research and research development,
via the Data Use Certification (DUC),
and (2) individuals who request
permission to submit data to the NDA
for the purpose of scientific
investigation, scholarship or teaching,
or other forms of research and research

development, via the Data Submission
Agreement (DSA). The extensive
information stored in the NDA
continues to provide a rare and valuable
scientific resource to the field, and plays
an integral part in fulfilling research
objectives in multiple scientific
domains. The NIH and the NIMH seek
to encourage use of the NDA by
investigators in the field of multiple
scientific research domains to achieve
rapid scientific progress. In order to take
full advantage of this resource and
maximize its research value, it is
important that data are made broadly
available, on appropriate terms and
conditions, to the largest possible
number of investigators.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1,500.

ESTIMATED ANNUALIZED BURDEN HOURS

NDA Data Submission Agreement
(DSA).
NDA Data Use Certification (DUC) ...

Researchers submitting data ...........

250

1

90/60

375

Researchers requesting access to
data.

750

1

90/60

1125

...........................................................

1000

1000

........................

1500

Melba Rojas,
Project Clearance Liaison, NIMH, NIH.
[FR Doc. 2017–21267 Filed 10–3–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
Waiver of Compliance With Navigation
Laws; Hurricane Maria
Office of the Secretary,
Department of Homeland Security.
ACTION: Notice.
AGENCY:

sradovich on DSK3GMQ082PROD with NOTICES

Average
burden per
response
(in hours)

Type of
respondents

Total ...........................................

Hurricane Maria struck Puerto Rico
resulting in widespread damage to its
infrastructure. In light of this
devastation, the Department of Defense
(DoD) has requested a 10-day waiver of
the Jones Act in the interest of national
defense, commencing immediately.
The Jones Act, 46 United States Code
(U.S.C.) 55102, states ‘‘a vessel may not
provide any part of the transportation of
merchandise by water, or by land and
water, between points in the United
States to which the coastwise laws

VerDate Sep<11>2014

20:18 Oct 03, 2017

Jkt 244001

Number of
respondents

Number of
responses per
respondent

Form name

apply, either directly or via a foreign
port’’ unless the vessel was built in and
documented under the laws of the
United States and is wholly owned by
persons who are citizens of the United
States. Such a vessel, after obtaining a
coastwise endorsement from the U.S.
Coast Guard, is ‘‘coastwise-qualified.’’
The coastwise laws generally apply to
points in the territorial sea, which is
defined as the belt, three nautical miles
wide, seaward of the territorial sea
baseline, and to points located in
internal waters, landward of the
territorial sea baseline.
The navigation laws, including the
coastwise laws, can be waived under the
authority provided by 46 U.S.C. 501.
The statute provides in relevant part,
‘‘On request of the Secretary of Defense,
the head of an agency responsible for
the administration of the navigation or
vessel-inspection laws shall waive
compliance with those laws to the
extent the Secretary considers necessary
in the interest of national defense.’’ 46
U.S.C. 501(a).
For the reasons stated above, and in
light of the request from the Department
of Defense, I am exercising my authority

PO 00000

Frm 00044

Fmt 4703

Sfmt 9990

Total annual
burden hours

to waive the Jones Act for a 10-day
period, commencing immediately, to
facilitate movement of all products to be
shipped from U.S. coastwise points to
Puerto Rico. This waiver applies to
covered merchandise laded on board a
vessel within the 10-day period of the
waiver and delivered by October 18,
2017. Carriers or shippers who conduct
transportation pursuant to this waiver
should provide notice of the vessel,
dates of embarkation and
disembarkation, type and quantity of
cargo, and port of embarkation to
JonesActWaiverRequest@cbp.dhs.gov.
Executed this 28th day of September, 2017.
Elaine C. Duke,
Acting Secretary of Homeland Security.
[FR Doc. 2017–21283 Filed 10–3–17; 8:45 am]
BILLING CODE 9111–14–P

E:\FR\FM\04OCN1.SGM

04OCN1